101 related articles for article (PubMed ID: 8588998)
1. Qualitatively different mechanisms of resistance to doxorubicin, both involving altered glutathione pools, in two myeloid cell lines in vitro.
Dajani LK; Warren DJ; Andersen A; Strømhaug A; Slørdal L
Pediatr Hematol Oncol; 1995; 12(6):531-44. PubMed ID: 8588998
[TBL] [Abstract][Full Text] [Related]
2. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
Kim WJ; Kakehi Y; Yoshida O
Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line.
Raghu G; Pierre-Jerome M; Dordal MS; Simonian P; Bauer KD; Winter JN
Int J Cancer; 1993 Mar; 53(5):804-11. PubMed ID: 8095491
[TBL] [Abstract][Full Text] [Related]
4. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
Lau DH; Lewis AD; Ehsan MN; Sikic BI
Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
[TBL] [Abstract][Full Text] [Related]
5. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
[TBL] [Abstract][Full Text] [Related]
6. Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Inhibition of glutathione S-transferase p1-1 by glutathione conjugates from anthracyclines.
Gaudiano G; Koch TH; Lo Bello M; Nuccetelli M; Ravagnan G; Serafino A; Sinibaldi-Vallebona P
Biochem Pharmacol; 2000 Dec; 60(12):1915-23. PubMed ID: 11108808
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and pharmacological characterization of MCF-7 drug-sensitive and AdrR multidrug-resistant human breast tumor xenografts in athymic nude mice.
Mimnaugh EG; Fairchild CR; Fruehauf JP; Sinha BK
Biochem Pharmacol; 1991 Jul; 42(2):391-402. PubMed ID: 1677569
[TBL] [Abstract][Full Text] [Related]
8. Intracellular glutathione level and efflux in human melanoma and cervical cancer cells differing in doxorubicin resistance.
Drozd E; Gruber B; Marczewska J; Drozd J; Anuszewska E
Postepy Hig Med Dosw (Online); 2016 Apr; 70():319-28. PubMed ID: 27117108
[TBL] [Abstract][Full Text] [Related]
9. Decreased sensitivity to adriamycin in cadmium-resistant human lung carcinoma A549 cells.
Hatcher EL; Alexander JM; Kang YJ
Biochem Pharmacol; 1997 Mar; 53(5):747-54. PubMed ID: 9113095
[TBL] [Abstract][Full Text] [Related]
10. Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes.
Hao XY; Bergh J; Brodin O; Hellman U; Mannervik B
Carcinogenesis; 1994 Jun; 15(6):1167-73. PubMed ID: 8020151
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
12. Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells.
Asakura T; Ohkawa K; Takahashi N; Takada K; Inoue T; Yokoyama S
Br J Cancer; 1997; 76(10):1333-7. PubMed ID: 9374380
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of doxorubicin resistance in human leukemia HL-60 cells is reproducibly associated with 7q21 chromosomal anomalies.
Ganapathi R; Hoeltge G; Casey G; Grabowski D; Neelon R; Ford J
Cancer Genet Cytogenet; 1996 Feb; 86(2):116-9. PubMed ID: 8603335
[TBL] [Abstract][Full Text] [Related]
14. [Valproic acid induced intracellular GSH-redox imbalance and apoptosis of leukemic cells resistant to dexamethasone and doxorubicin].
Liu H; Fu RY; Liao QK; Li FY; Zhu YP; Gao J; Mao YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):133-7. PubMed ID: 19292063
[TBL] [Abstract][Full Text] [Related]
15. Methyl-beta-cyclodextrin in HL-60 parental and multidrug-resistant cancer cell lines: effect on the cytotoxic activity and intracellular accumulation of doxorubicin.
Grosse PY; Bressolle F; Pinguet F
Cancer Chemother Pharmacol; 1997; 40(6):489-94. PubMed ID: 9332463
[TBL] [Abstract][Full Text] [Related]
16. Cell-specific modulation of drug resistance in acute myeloid leukemic blasts by diphtheria fusion toxin, DT388-GMCSF.
Frankel AE; Hall PD; McLain C; Safa AR; Tagge EP; Kreitman RJ
Bioconjug Chem; 1998; 9(4):490-6. PubMed ID: 9667951
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of apoptosis is the cause of resistance to doxorubicin in human breast adenocarcinoma cells.
Osmak M; Brozović A; Ambriović-Ristov A; Hadzija M; Pivcević B; Smital T
Neoplasma; 1998; 45(4):223-30. PubMed ID: 9890665
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase and glutathione peroxidase are essential in the early stage of adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells.
Lee WP; Lee CL; Lin HC
Cancer Chemother Pharmacol; 1996; 38(1):45-51. PubMed ID: 8603451
[TBL] [Abstract][Full Text] [Related]
19. Role of glutathione S-transferases in the resistance of human colon cancer cell lines to doxorubicin.
Beaumont PO; Moore MJ; Ahmad K; Payne MM; Lee C; Riddick DS
Cancer Res; 1998 Mar; 58(5):947-55. PubMed ID: 9500455
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
